Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Sun Pharma Buys Organon
Description
India's Sun Pharmaceutical Industries agreed to acquire Organon for $11.75B at $14 per share, positioning Sun as a top-three player in global women's health. Organon sells contraceptives including Nexplanon and fertility drug Follistim, reporting $6.2B in 2025 revenue. Organon shares rose 17.2% to $13.20 Monday. The deal is expected to close in early 2027 pending approvals and will be funded with cash and bank financing.
More from User
00:55
Apple Hikes Incoming
Benzinga
00:58
Trump Settles Niece Lawsuit
Benzinga
00:58
House Eyes Airline Rules
Benzinga
00:57
Intel-Apple Deal
Benzinga
00:50
Senate Targets Buybacks
Benzinga
00:58
CarMax Stock Sinks
Benzinga
Related Videos
10:07
Market Headstart: Nifty likely to open higher; Siemens, Sun Pharma top buys
Moneycontrol
03:29
Buy or Sell | Remain stock specific in short term; buy ONGC, Sun Pharma
Moneycontrol
04:31
Buy ICICI Bank and Sun Pharma: Deepak Mohoni
ET NOW
08:34
We are still not taking buying call on Lupin, Cipla & Sun Pharma, says market guru SP Tulsian
CNBC-TV18
02:28
Stock Ideas: Sell Jet Airways, IDFC; Buy Sun Pharma
ET NOW
02:23
Sun Pharma to buy Ranbaxy in $3.2 bn deal
ET NOW